BRPI1014688A2 - therapeutic applications of quinazolinadione derivatives - Google Patents

therapeutic applications of quinazolinadione derivatives

Info

Publication number: BRPI1014688A2
Authority: BR; Brazil
Prior art keywords: quinazolinadione; derivatives; therapeutic applications; therapeutic; applications
Prior art date: 2009-03-27

Application number

BRPI1014688A

Other languages

Portuguese (pt)

Inventor

Fabrice Viviani

Gilbert Marciniak

Jean-François Nave

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-27

Filing date

2010-03-25

Publication date

2016-04-12

2010-03-25 Application filed by Sanofi Sa filed Critical Sanofi Sa

2016-04-12 Publication of BRPI1014688A2 publication Critical patent/BRPI1014688A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

BRPI1014688A 2009-03-27 2010-03-25 therapeutic applications of quinazolinadione derivatives BRPI1014688A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0901460A FR2943673B1 (en)	2009-03-27	2009-03-27	THERAPEUTIC APPLICATIONS OF QUINAZOLINEDIONE DERIVATIVES
PCT/FR2010/050549 WO2010109148A1 (en)	2009-03-27	2010-03-25	Therapeutic uses of quinazolinedione derivatives

Publications (1)

Publication Number	Publication Date
BRPI1014688A2 true BRPI1014688A2 (en)	2016-04-12

Family

ID=41203772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1014688A BRPI1014688A2 (en)	2009-03-27	2010-03-25	therapeutic applications of quinazolinadione derivatives

Country Status (30)

Country	Link
US (1)	US8748441B2 (en)
EP (1)	EP2411009B8 (en)
JP (1)	JP5654559B2 (en)
KR (1)	KR101686263B1 (en)
CN (1)	CN102448461B (en)
AR (1)	AR075955A1 (en)
AU (1)	AU2010227359B2 (en)
BR (1)	BRPI1014688A2 (en)
CA (1)	CA2756645A1 (en)
CL (1)	CL2011002382A1 (en)
CO (1)	CO6430429A2 (en)
CY (1)	CY1114400T1 (en)
DK (1)	DK2411009T3 (en)
EA (1)	EA023670B1 (en)
ES (1)	ES2411880T3 (en)
FR (1)	FR2943673B1 (en)
HR (1)	HRP20130538T1 (en)
IL (1)	IL215368A0 (en)
MA (1)	MA33218B1 (en)
MX (1)	MX2011010150A (en)
NZ (1)	NZ595405A (en)
PL (1)	PL2411009T3 (en)
PT (1)	PT2411009E (en)
SG (1)	SG174931A1 (en)
SI (1)	SI2411009T1 (en)
SM (1)	SMT201300067B (en)
TW (1)	TWI471313B (en)
UY (1)	UY32526A (en)
WO (1)	WO2010109148A1 (en)
ZA (1)	ZA201107009B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2944206B1 (en) *	2009-04-09	2012-12-28	Sanofi Aventis	THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES
US9220715B2 (en)	2010-11-08	2015-12-29	Omeros Corporation	Treatment of addiction and impulse-control disorders using PDE7 inhibitors
EP4275752A3 (en) *	2010-11-08	2024-02-21	Omeros Corporation	Treatment of addiction and impulse-control disorders using pde7 inhibitors
AU2013266793B2 (en) *	2012-05-07	2016-08-04	Omeros Corporation	Treatment of addiction and impulse-control disorders using PDE7 inhibitors
WO2013177349A2 (en) *	2012-05-25	2013-11-28	Glaxosmithkline Llc	Quinazolinediones as tankyrase inhibitors
US9499496B2 (en)	2012-06-05	2016-11-22	University Of Kansas	Inhibitors of respiratory syncytial virus
KR102316234B1 (en)	2018-07-26	2021-10-22	주식회사 종근당	1,3,4-Oxadiazole Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same
TWI748491B (en) *	2019-05-31	2021-12-01	韓商鐘根堂股份有限公司	1,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
RU2715884C1 (en) *	2019-06-24	2020-03-04	федеральное государственное автономное образовательное учреждение высшего образования "Северо-Кавказский федеральный университет"	2-benzyl derivative of 4-(3h)quinazolinone, having analgesic, anti-parkinsonian, antihypoxant, tranquilising action
KR102685058B1 (en) *	2020-09-02	2024-07-15	주식회사 종근당	Novel Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same
RU2758333C1 (en) *	2021-03-22	2021-10-28	федеральное государственное автономное образовательное учреждение высшего образования "Северо-Кавказский федеральный университет"	Quinazolin-4(3h)-one dimethoxybenzylsulfo derivative with analgesic, antiparkinsonian, anxiolytic, psychostimulating activity
CN119768172A (en)	2022-08-18	2025-04-04	米托迪治愈有限责任公司	Use of therapeutic agents having phosphodiesterase-7 inhibitory activity in the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertion intolerance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH23853A (en) *	1986-08-21	1989-11-23	Pfizer	Pyridopyrimidinediones
US6323201B1 (en) *	1994-12-29	2001-11-27	The Regents Of The University Of California	Compounds for inhibition of ceramide-mediated signal transduction
WO1996036638A1 (en) *	1995-05-19	1996-11-21	Chiroscience Limited	Xanthines and their therapeutic use
JP2002308774A (en) *	2001-04-12	2002-10-23	Nippon Zoki Pharmaceut Co Ltd	Iv-type phosphodiesterase selective inhibitor
EP1348701A1 (en) *	2002-03-28	2003-10-01	Warner-Lambert Company LLC	(2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
WO2006003148A1 (en) *	2004-06-30	2006-01-12	Janssen Pharmaceutica N.V.	Quinazolinedione derivatives as parp inhibitors
CN101917992A (en) *	2007-03-27	2010-12-15	奥默罗斯公司	Use of PDE7 inhibitors for the treatment of movement disorders
FR2921926B1 (en) *	2007-10-03	2009-12-04	Sanofi Aventis	QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATIONS THEREOF.

2009
- 2009-03-27 FR FR0901460A patent/FR2943673B1/en not_active Expired - Fee Related
2010
- 2010-03-25 SG SG2011069978A patent/SG174931A1/en unknown
- 2010-03-25 ES ES10715983T patent/ES2411880T3/en active Active
- 2010-03-25 DK DK10715983.2T patent/DK2411009T3/en active
- 2010-03-25 KR KR1020117025278A patent/KR101686263B1/en not_active Expired - Fee Related
- 2010-03-25 MA MA34279A patent/MA33218B1/en unknown
- 2010-03-25 AU AU2010227359A patent/AU2010227359B2/en not_active Ceased
- 2010-03-25 PT PT107159832T patent/PT2411009E/en unknown
- 2010-03-25 EP EP10715983.2A patent/EP2411009B8/en active Active
- 2010-03-25 NZ NZ595405A patent/NZ595405A/en not_active IP Right Cessation
- 2010-03-25 JP JP2012501361A patent/JP5654559B2/en not_active Expired - Fee Related
- 2010-03-25 BR BRPI1014688A patent/BRPI1014688A2/en not_active IP Right Cessation
- 2010-03-25 MX MX2011010150A patent/MX2011010150A/en active IP Right Grant
- 2010-03-25 US US13/259,888 patent/US8748441B2/en not_active Expired - Fee Related
- 2010-03-25 CN CN201080023180.5A patent/CN102448461B/en not_active Expired - Fee Related
- 2010-03-25 WO PCT/FR2010/050549 patent/WO2010109148A1/en not_active Ceased
- 2010-03-25 EA EA201171172A patent/EA023670B1/en not_active IP Right Cessation
- 2010-03-25 SI SI201030235T patent/SI2411009T1/en unknown
- 2010-03-25 CA CA2756645A patent/CA2756645A1/en not_active Abandoned
- 2010-03-25 PL PL10715983T patent/PL2411009T3/en unknown
- 2010-03-25 HR HRP20130538AT patent/HRP20130538T1/en unknown
- 2010-03-26 AR ARP100100966A patent/AR075955A1/en unknown
- 2010-03-26 TW TW99109237A patent/TWI471313B/en not_active IP Right Cessation
- 2010-03-26 UY UY0001032526A patent/UY32526A/en not_active Application Discontinuation
2011
- 2011-09-25 IL IL215368A patent/IL215368A0/en unknown
- 2011-09-26 ZA ZA2011/07009A patent/ZA201107009B/en unknown
- 2011-09-27 CL CL2011002382A patent/CL2011002382A1/en unknown
- 2011-09-27 CO CO11126036A patent/CO6430429A2/en not_active Application Discontinuation
2013
- 2013-06-19 SM SM201300067T patent/SMT201300067B/en unknown
- 2013-06-20 CY CY20131100504T patent/CY1114400T1/en unknown

Also Published As

Publication number	Publication date
KR101686263B1 (en)	2016-12-13
MX2011010150A (en)	2011-12-14
US8748441B2 (en)	2014-06-10
JP2012521974A (en)	2012-09-20
PT2411009E (en)	2013-05-27
MA33218B1 (en)	2012-04-02
EP2411009A1 (en)	2012-02-01
JP5654559B2 (en)	2015-01-14
EP2411009B8 (en)	2013-06-26
UY32526A (en)	2010-10-29
ZA201107009B (en)	2012-11-28
CY1114400T1 (en)	2016-08-31
EA023670B1 (en)	2016-06-30
PL2411009T3 (en)	2013-09-30
CN102448461B (en)	2014-08-06
ES2411880T3 (en)	2013-07-09
SI2411009T1 (en)	2013-07-31
CL2011002382A1 (en)	2012-02-17
TWI471313B (en)	2015-02-01
HRP20130538T1 (en)	2013-07-31
AU2010227359A1 (en)	2011-10-20
DK2411009T3 (en)	2013-06-24
KR20120003904A (en)	2012-01-11
HK1164721A1 (en)	2012-09-28
FR2943673B1 (en)	2013-03-29
CA2756645A1 (en)	2010-09-30
CO6430429A2 (en)	2012-04-30
TW201038539A (en)	2010-11-01
EA201171172A1 (en)	2012-04-30
WO2010109148A1 (en)	2010-09-30
SMT201300067B (en)	2013-09-06
FR2943673A1 (en)	2010-10-01
NZ595405A (en)	2013-03-28
CN102448461A (en)	2012-05-09
IL215368A0 (en)	2011-12-29
SG174931A1 (en)	2011-11-28
AR075955A1 (en)	2011-05-11
AU2010227359B2 (en)	2016-08-04
US20120058987A1 (en)	2012-03-08
EP2411009B1 (en)	2013-03-20

Publication	Publication Date	Title
CY2020008I1 (en)	2020-11-25	PHARMACEUTICAL FORMS OF DISTROMAT TABLET
BRPI1014688A2 (en)	2016-04-12	therapeutic applications of quinazolinadione derivatives
SMT201600075B (en)	2016-04-29	COMPOSED OF HETEROCYCLIC DIAMMINOCARBOSSIDE
EP2265283A4 (en)	2012-04-25	AURISTATINE-LIEUR CONJUGATES OF MEDICINE
PT2414890T (en)	2017-12-26	MANUFACTURE OF ELECTROCHROMIC DEVICES OF LOW DEFETIVITY
DOP2012000114A (en)	2012-08-15	BROMODOMINIUM INHIBITOR OF BENZODIAZEPINA
PT2493478T (en)	2018-04-03	CONCENTRATED THERAPEUTIC COMPOSITIONS OF PHOSPHOLIPIDS
EP2399504A4 (en)	2012-12-05	SCOPE OF APPLICATION DEVICE
LT3222272T (en)	2021-12-27	PHARMACEUTICAL COMPOSITION OF CARBETOCINE
EP2419392A4 (en)	2013-02-27	EMULSIONS OF PERFLUOROCARBONES
EP2442821A4 (en)	2013-07-31	SAFE ADMINISTRATION OF DESMOPRESSINE
EP2641343A4 (en)	2014-04-16	CONFIGURATION OF SUBFRAME
EP2418213A4 (en)	2012-12-19	DERIVATIVE OF NEUROMEDIN U
PL2493466T3 (en)	2021-11-15	NEW ANTI-TUMBLE APPLICATION OF CABAZYTAXEL
SMT201500268B (en)	2016-01-08	DERIVATIVE OF 5-HYDROXYPIRYMIDIN-4-CARBOSSAMIDE
DK2453858T3 (en)	2014-11-03	COURSE OF ACTION
IT1398296B1 (en)	2013-02-22	ARRANGEMENT OF SENSORS
EP2498298A4 (en)	2013-11-06	MODULE OF PHOTOPILES
DK2501381T3 (en)	2017-11-06	TREATMENT OF ATRIE FLIMS
CU23884B1 (en)	2013-04-19	DERIVATIVES OF DIBENZOTIAZEPINA
EP2623503A4 (en)	2014-03-05	DERIVATIVES OF CROMENE
PT2774612T (en)	2017-11-17	FORMULATIONS OF 4-METHYLPYRAZOLE
BRPI1011318A2 (en)	2019-09-24	triazine derivatives and their therapeutic applications
EP2595966A4 (en)	2015-12-09	SYNTHESIS OF CYCLOPENTAQUINAZOLINES
BR112012000079A2 (en)	2017-07-25	fluorinated derivatives of 3-hydroxypyridin-4-ones

Legal Events

Date	Code	Title	Description
2017-02-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-05-23	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]